| Date | Title | | | 02/22/12 | Abiomed to Present at Citi 2012 Global Healthcare Conference| DANVERS, Mass.--(BUSINESS WIRE)--Feb. 22, 2012--
Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today announced that Michael R. Minogue, Chairman,
President and Chief Executive Officer, will present at the Citi 2012
Global Healthcare Conference on Tuesday, February 28, 2012 at 9:30 a.m.
ET. The conference will be held at the Waldorf Astoria Hotel in New York
City.
ABOUT ABIOMED
... |
|  | | 02/03/12 | Abiomed Reports Record Revenue of $32.2 Million and Earnings of $2.9 Million for Third Quarter of Fiscal 2012|
-- Worldwide Impella Revenue Totals $27.7 Million, Up 31% With
Double Digit Sequential and Year over Year Growth in Impella Utilization
DANVERS, Mass.--(BUSINESS WIRE)--Feb. 3, 2012--
Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today reported third quarter fiscal 2012 revenue
of $32.2 million, up 18% compared to revenue of $27.2 million in the
same period of fiscal 2011 and GAAP net inco... |
| | | 01/31/12 | New Clinical Data for Symphony Presented in Late Breaking Clinical Trials Session at the Society of Thoracic Surgeons 2012 Annual Meeting| FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 31, 2012--
Abiomed
Inc. (NASDAQ: ABMD), a leading provider of breakthrough
heart support technologies, today announced that the initial
clinical data from the safety study for Symphony™ was presented by Renzo
Cecere, M.D., FRCSC, FACS, Associate Professor of Surgery at McGill
University, during the late-breaking clinical trials session at the
Society of Thoracic Surgeons (STS) 2012 Annual Meeting in... |
| | | 01/26/12 | Abiomed Third Quarter Fiscal 2012 Earnings and Conference Call Notification| DANVERS, Mass.--(BUSINESS WIRE)--Jan. 26, 2012--
Abiomed,
Inc. (NASDAQ: ABMD) announced today that on Friday, February 3, the
Company will release financial results for the third quarter of fiscal
2012. The Company will host a conference call to discuss the results on
Friday, February 3, 2012, at 8:00 a.m. ET. Michael R. Minogue, Chairman,
President and Chief Executive Officer and Robert L. Bowen, Vice
President and Chief Financial Officer, wi... |
| |
|
